With numerous planned submissions underway for 2024, the new platform is setting a new standard for managing simultaneous ...
Dynavax is giving up work on its combination vaccine for tetanus, diphtheria and acellular pertussis (Tdap) after mulling phase 1 data for the shot. | Dynavax is giving up on its combination vaccine ...
Board of Directors recently welcomed five new members: Christine Helfenbein, David Milligan, Milton Nagel, Talli Oxnam and ...
Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...
Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...
Also last year, the FTC blocked Sanofi’s proposed acquisition of a drug in development for Pompe disease, a genetic condition ...
The safety results from the EoE KIDS study were consistent with the known safety profile of Dupixent in adolescents and ...
AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...
Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...
They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback